SCHEMBL14256736

SCHEMBL14256736

CC(C)(C)OC(=O)N1CCC(Nc2nc(NCc3ccccc3Sc3ccccc3CO)nc3ccccc23)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNMT3A Q9Y6K1 2/20 0.53
▸ EHMT2 Q96KQ7 4/20 0.50
▸ KDM1A O60341 3/20 0.50
▸ RCOR1 Q9UKL0 2/20 0.50
▸ NSD2 O96028 1/20 0.45
▸ ACHE P22303 2/20 0.44
▸ WHR1 P49842 1/20 0.42
▸ MAPT P10636 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ TYRO3 Q06418 1/20 0.40
▸ MERTK Q12866 1/20 0.40
▸ GAS6 Q14393 1/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14266659 0.89 EHMT2 (0.42) DNMT3AEHMT2KDM1ARCOR1ACHE
SCHEMBL14256734 0.87 EHMT2 (0.47) DNMT3AEHMT2KDM1ARCOR1NSD2
SCHEMBL14412273 0.84 EHMT2 (0.44) DNMT3AEHMT2KDM1ARCOR1ACHE
SCHEMBL14256741 0.82 WHR1 (0.45) DNMT3AEHMT2KDM1ANSD2ACHE
SCHEMBL14256444 0.81 MERTK (0.53) ACHEWHR1MERTK
SCHEMBL14412253 0.81 PDE5A (0.45) DNMT3AEHMT2KDM1ANSD2ACHE
SCHEMBL14256699 0.81 MERTK (0.52) ACHEMERTK
SCHEMBL9911790 0.80 EHMT2 (0.75) DNMT3AEHMT2KDM1ARCOR1
SCHEMBL14412248 0.80 APP (0.45) EHMT2KDM1AACHEWHR1ALDH1A1
SCHEMBL14412272 0.79 CXCR4 (0.52) ACHEWHR1MAPTALDH1A1MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF DNMT3A 1041/4885EHMT2 1276/4885KDM1A 3012/4885
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF DNMT3A 832/4885EHMT2 1177/4885KDM1A 2734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback